Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LivaNova PLC | President, Global Epilepsy | Stock Appreciation Rights | 15.4K | $1.26M | $82.04 | Mar 30, 2025 | Direct |
LivaNova PLC | President, Global Epilepsy | Ordinary Shares | 12.8K | $499K | $39.13 | Mar 30, 2025 | Direct |
LivaNova PLC | President, Global Epilepsy | Restricted Stock Units | 7.03K | $385K | $54.81 | Mar 30, 2025 | Direct |
LivaNova PLC | President, Global Epilepsy | Performance Stock Units | 7.03K | Mar 30, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LIVN | LivaNova PLC | Mar 30, 2025 | 14 | -$111K | 4 | Apr 1, 2025 | President, Global Epilepsy |
LIVN | LivaNova PLC | Mar 30, 2024 | 14 | -$204K | 4 | Apr 2, 2024 | President, Global Epilepsy |
LIVN | LivaNova PLC | Mar 1, 2024 | 0 | $0 | 3 | Mar 11, 2024 | President, Global Epilepsy |